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in 6 centers participating in the Medicare Heart Bypass Demonstration were 
analyzed by quantitative computeflzed coronary angiagrapby (QCA). QCA 
estimates of % stenosls (% St) in 350 lesions were compared to hospitals' 
visual estimates (HV). 
HV-QCA differences L, etween hospitals were significant (p < 0.01) after 
controlling for pt charactedstius in multiple regression analyses. 
CencJus/ons: Hospitals vary widely in the magnitude of the discrep~ulcy 
between visual and objective computerized estimates of % St and in the 
proportion of critical esions =,danflfied. This large variability between hoepitais 
has potentially important |nlpUcatione with regard Io the decision making 
threshold to perform CABG. Improved standardization of the methods u,~ed 
to interpret coronary angiagrams is needed. 
~-~The Pedcardlal Valve in the Small Aortic Edwards 
Root: Hemodynamics and Evidence for Regression 
of  Hypertrophy 
Stsven Khan, Ashish Parikh, Shalla Kar, Michele DeRobertis, 
Aurello Chats, Robert Siegel. C, edam-Sinai Medical Center, Los Angeles, 
CA 
Traditionally, tissue valves have not been implanted in patients with small 
aortic roots (SAR) due to poor hemodynamki performance. However, the 
improved hamodynamics of the Carpontier-Edwards padcardial valve (CEP) 
have led to its use in SAR patients who previously would have received 
mechanical valves, lo  evaluate the late hemodynamio performance of the 
CEP valve and regression of left ventdcular hypertrophy (LVH) we StL¢lied 37 
patients at least one year (mean 19 months) after AVR by ecllec~m'iographic 
and EKG criteria. 
Results: 
Valve Hemodynamtcs Valve Size (ram) 
19(n=4) 21(n=21) 23(n=12) 
Valve Area (cm 2) 1.1 1.3 1.5 
Mean Gradient (mmHg) 18.5 18.5 15.7 
VtN2 Ratio 0.43 0.42 0.48 
Peak and mean gredients decreased from 81 to 29 mmHg and from 48 to 18 
mmHg respectively. The mean LVEDD and LVESD decreased from 4.7 crn to 
4A crn and from 3.0 to 2.9 (both P < 0.05). Mean septai thickness decreased 
from 1.30 cnl to 1.17 cm (P < 0.01 ). Mean posterior wail thickness decreased 
from 1.27 cm to 1.12 cm (P = 0.02) while ejection fraction increased from 
61% to 66%. EKG LVH was present in 69% of patients preoperatively and 
430 postoperatively. 
Conclusion: The CE Pedcardiai valve demonstrates good hemodynamic 
performance at one year after surgery in patients with small aortic roots. 
There is corresponding evidence of regression of LVH by bath echo and 
EKG cdteda. 
~ Mitral Valve Repair in Elderly: Degenerative the 
Versus Ischemic Mltral Regurgitation 
Antone J. Tatooles, Saw R Aranki, David H. Adams, Gregory S. Couper, 
Robert J. Rizzo, John J. Collins, Lawrence H, Cohn. Brigham and Women's 
Hosp/ta/, Boston, MA 
The clinical outcome for elderly patients (> 70) undergoing mitral valve repair 
for mitral regurgitation (MR) is asyet undefined. From 1/85-1/95 155 patients 
>_ 70 years of age underwent mitral valve repair for either dagenemtive mitral 
mgurgitetion (DMR) 114 patients, or ischemlo mitrai regurgitation (IMR) 41 
patients. Associated CABG was done in 39141 IMR patients and 44/114 
DMR patients. In the IMR group 49% were functional class IV and 41% had 
an ejection fraction below 40% versus the DMR group in which 16% were 
functional class IV and 3% had an ejection fraction below 40%. The operative 
mortality for DMR was 4/114 (3.5%) vemus 9141 for IMR (22%) (p < 0.005). 
Long term follow-up indicated freedom from thromboemboli was 93% in DMR 
group versus 92% in IMR group without anti-coagulation; 10/110 surviving 
DMR patients required moperatlon (9%). 
These results demonstrate mitral valve repair In the elderly for degener- 
ative mitral regurgitation an be carded out at low dsk and excellent long 
term results. In contrast repair of the degenerative Ischemic mitrai valve has 
a significant early operative mortality. Better selection of patients, particu- 
lady in the elderly group seems warranted in patients with ischemic mitral 
regurgitation. 
• Differential Alterations of Type Ig and W Collagen 
Protein Expression in Experimental Venous 
Bypass Grafting 
Bdan H. Annex, Stephan M. Denning, Gregory C. Fulton, Keith 
,A. Channon, Mark G. Davies, Per-Otto Hagen. Divisions of Cardiology and 
Exl:~.rirnental Surgery, Duke University Medical Center, Durham, NC 
1,'lti,-nal hyperplasia (IH) is the precursor of vein graft (VG) atherosclero- 
sis. Collagens am a family of genetically distinct proteins which accumulate 
dunng the development of IH and VG athemsderosis. Using immunohis- 
fochemical techniques, we examined changes in collagen III (fibdllar) and 
IV (basement membrane) protein expression following interpositional venous 
bypass graffing in rabbits. Control jugular veins (CV, n = 6) and VGs harvested 
3 days (n = 6), 7 days (n = 3) and 28 days (n = 4) after surgery were studied 
to represent ordferent s sges in the development of IH. The specir~ties of the 
anticollagen antibodies were confirmed on histclegic sectmns nt rabbit skin. 
In CV, collagen IV was expressed over the entire (100%) intima. In the 3 
day VG (pre-IH), collagen IV was expressed over approximately 50% of the 
Intimai area and was notably absent in regions of inflammatory infiltration. In 
the 7 day VG (early IH), collagen IV was entirely absent in the inttma, bot, in 
the 29 day VG (maximal IH) collagen IV was expressed over most (>75%) 
of the area of intima. In striking contrast, collagen III was absent in the intima 
of the control, 3 day and 28 day VGs but was faintly detected in the inflma 
of the 7 day VG. In conclusion: Collagen subtypes express different patterns 
of change in response to venous bypass grafting. In particular, collagen IV 
demonstrates dramatic alterations in protein expression dudng the formation 
of IH which may provide unique targets for therapy. 
[~- '~  22-Year Rates of  Crossover and Reoperation in the 
VA Cooperative Study of  Coronary Artery Bypass 
Surgery for  Stable Angina 
Peter Peduzzi, Katherine Detre, Ayumi Kamina. VA Coeperative Studies 
Program, West Haven, CT 
The VA randomized trial of medical (M) vs surgical (S) therapy enrolled 
686 patients (354 M, 3,32 S) between 1972-74 who had stable angina 
and angiographloaily documented coronary artery disease (50% cdtedon). 
Median follow-up was 21 years; 18 patients were lost to follow-up. 312 
S patients had bypass surgery (operate mortality = 5.8%) a,d 78 had 
second surgery (operative mortality = 10.3%). 160 M patients crossed over 
to S in 22 years (operative mortality = 4.4%) arid 33 had second surgery 
(operailve mortality = 9.1%). Ranpemtion and crossover ates were evaluated 
in angiographie (eng.) and clinical subgroups of patients without left main 
disease. Ang. high dsk was defined as 3-vessel diseese with impaired left 
ventdcular function; all others were dassitlod as low dsk. Low, mid and high 
clinical dskgroups were based on a multivadste risk function using 4 baseline 
factors: resting ST segment depression, history of MI, history of hypertension 
and New York Heart Functional Class III + IV vs I + I1.22-ynar cumulative 
rates were: 
M Crossover S Reoperatien 
N Rate N Rate 
All pts 354 0.66 332 0.45 
Ang. low dsk 211 0,63 210 0.45 
Ang. high risk 97 0.69 71 0.46 
Clinical low risk 123 0.64 113 0.48 
Clinical mid risk 91 0.66 84 0.44 
Clinical high dsk 94 0.57 83 0.43 
We conclude that crossover and reepemtion rates were not related tO 
baseline risk. Operative mortality was two times higher for reoperatlen. 
Post-Transplant Vasculopathy 
Tuesday, March 26, 1996, 9:00 a.m.--11:00 a.m. 
Orange County Convention Center, Hall E 
Presentation Hour: 10:00 a.m.-11:00 a.m. 
~4~'~ Activated Plateleta From Heart Patients Transplant 
on Cyclespodne Therapy Release Free Radicals 
That Impair Platelet-Mediated 
Endathellum-D~-kendent Vseodilatation 
Heigi J. Oskarsson, 11mothy H~.{::leyer, Maria-Teresa Olivan. University of 
Nebraska Medi~' Cent~, Omaha, NE 
Cyclospodne (CyA) impaira the ability of platolets to mediate vasodistion, 
both in vitro and in vlvo. The purpose of this study was to elucidate the 
mechanism(s) for this platslet defect. Pits were isolated from heart transplant 
